SanBio saw the highest growth of 0.99% in patent filings in June and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of SanBio‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
SanBio has been focused on protecting inventions in United States(US) with three publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 33% grants. The United States(US), South Korea(KR), European Patent Office(EPO), and Australia(AU) patent Office are among the top ten patent offices where SanBio is filings its patents. Among the top granted patent authorities, SanBio has 33% of its grants in United States(US), 33% in South Korea(KR) and 33% in Australia(AU).
Mesoblast could be the strongest competitor for SanBio
Patents related to cell & gene therapy and rare diseases lead SanBio's portfolio
SanBio has the highest number of patents in cell & gene therapy followed by, rare diseases. For cell & gene therapy, nearly 60% of patents were filed and 100% of patents were granted in Q2 2024.
Rheumatoid arthritis related patents lead SanBio portfolio followed by multiple sclerosis, and diabetic neuropathy
SanBio has highest number of patents in rheumatoid arthritis followed by multiple sclerosis, diabetic neuropathy, acute lung injury, and globoid cell leukodystrophy (krabbe disease). For rheumatoid arthritis, nearly 10% of patents were filed and 11% of patents were granted in Q2 2024.
For comprehensive analysis of SanBio's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
